
New from @AyanaTRuffin and our team @PaulosLab @LesinskiLab in Cancer Research: TLR9 agonism boosts T cell therapy by activating B cells that provide critical CD2 costimulation: improving tumor control. A powerful B cell–T cell partnership. 🧬 pubmed.ncbi.nlm.nih.gov/42406997/




















